Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Adenocarcinoma mucinoso bien diferenciado de tipo gástrico (adenoma maligno): un reto diagnóstico

Gastric-type mucinous well differentiated adenocarcinoma (adenoma malignum): a diagnostic challenge.

Ginecol Obstet Mex. 2019 junio;87(6):410-416.

https://doi.org/10.24245/gom.v87i6.2948

Beatriz Díaz-Rabasa,1 Andrea Espiau-Romera,1 Paula Cebolla-Gil,1 Celia Del Agua,2 María Pilar Del Tiempo-Marqués,1 Isabel Negredo-Quintana1

1 Servicio de Ginecología.
2 Servicio de Anatomía patológica.
Hospital Universitario Miguel Servet, Zaragoza, España.


Corrrespondencia:

Beatriz Díaz Rabasa
beadiaz89@hotmail.com

Debe citarse como:

Díaz-Rabasa B, Espiau-Romera A, Cebolla-Gil P, Del Agua C, Del Tiempo-Marqués MP, Negredo-Quintana I. Adenocarcinoma mucinoso bien diferenciado de tipo gástrico (adenoma maligno): un reto diagnóstico. Ginecol Obstet Mex. 2019 junio;87(6):410-416. https://doi.org/10.24245/gom.v87i6.2948

Resumen

ANTECEDENTES: El adenocarcinoma mucinoso bien diferenciado de tipo gástrico (adenoma maligno) es una variante histológica poco frecuente de adenocarcinoma mucinoso cervical. La hidrorrea, el sangrado vaginal persistente y las formaciones quísticas cervicales son manifestaciones sugerentes de la enfermedad.

CASO CLÍNICO: Paciente de 52 años, que acudió a consulta por hidrorrea y sangrado genital persistente. Después de la exploración física se tomaron muestras de: exudado vaginal, citología cervical, biopsia endometrial e identificación de virus del papiloma humano. También se practicaron estudios de: colposcopia, legrado endocervical, ecografía transvaginal, histeroscopia y resonancia magnética. Se visualizaron múltiples quistes de Naboth, menores de 2 cm; líquido en la cavidad uterina y el canal endocervical, sin hallazgos patológicos adicionales. Por la persistencia de los síntomas se decidió efectuar la histerectomía total simple con doble anexectomía, por laparotomía. El reporte anatomopatológico fue: adenocarcinoma mucinoso bien diferenciado de tipo gástrico, estadio IB2 (FIGO). Se prescribieron: tratamiento coadyuvante, radioterapia externa y braquiterapia. Después de 12 esquemas de tratamiento no se identificaron signos de recidiva.

CONCLUSIONES: Establecer el diagnóstico anatomopatológico preoperatorio es decisivo para disminuir la morbilidad y mortalidad por adenocarcinoma mucinoso. Es importante establecer el diagnóstico diferencial exhaustivo con lesiones benignas cervicales.

PALABRAS CLAVE: Adenocarcinoma mucinoso cervical; sangrado vaginal; quistes cervicales; quiste de Naboth; diagnóstico diferencial.

Abstract

BACKGROUND: Gastric-type mucinous well differentiated adenocarcinoma (adenoma malignum) is an infrequent cervical mucinous adenocarcinoma. It must be suspected if persistent hydrorrhea or vaginal bleeding are present, as well as multiple cervical cysts.

CLINICAL CASE: A case of a 52-year-old woman with persistent hydrorrhea and vaginal bleeding. The study was completed with vaginal culture, cervical cytology and HPV (Human Papiloma Virus), colposcopy, endocervical curettage, transvaginal ultrasound, endometrial biopsy, hysteroscopy and magnetic resonance imaging. Multiple Nabothian cysts <2 cm and fluid in the uterine cavity and the endocervical canal were observed, with no other pathological findings. Due to the symptom persistence and severity, surgical treatment was decided, revealing the diagnosis of gastric-type mucinous well differentiated adenocarcinoma, stage IB2 (FIGO). Adjuvant treatment consisted in external radiotherapy and brachytherapy. After one year of follow-up, the patient did not show any sign of relapse.

CONCLUSIONS: Reaching a pathological diagnosis prior to surgery has a crucial importance to decrease morbi-mortality. A thorough differential diagnosis including benign cervical lesions is essential.

KEYWORDS: Cervical mucinous adenocarcinoma; Vaginal bleeding; Multiple cervical cysts; Nabothian Cyst; Differential diagnosis.

    1. Kamath GD, et al. A Rare case of adenoma malignum: preparing for the unforeseen. J Obstet Gynaecol India 2017;67(1):70-3. http://doi.org/10.1007/s13224-016-0895-x.
    2. Castán-Senar A, et al. Magnetic resonance imaging of adenoma malignum of the uterine cervix with pathologic correlation: a case report. Radiol Case Rep 2016;11(4):323-7. http://doi.org/10.1016/j.radcr.2016.08.008.
    3. Kojima A, et al. Gastric morphology and immunophenotype predict poor outcome in mucinous adenocarcinoma of the uterine cervix. Am J Surg Pathol 2007;31(5):664-72. http://doi.org/10.1097/01.pas.0000213434.91868.b0.
    4. Park SB, et al. Adenoma malignum of the uterine cervix: imaging features with clinicopathologic correlation. Acta Radiol 2013;54(1):113-20. http://doi.org/10.1258/ar.2012.120059.
    5. Talia KL, et al. The developing spectrum of gastric-type cervical glandular lesions. Pathology 2018;50(2):122-33. http://doi.org/10.1016/j.pathol.2017.09.009.
    6. Nishii Y, et al. Minimal deviation mucinous adenocarcinoma of the uterine cervix that proved difficult to differentiate from endometrial cancer: A case report. Oncol Lett 2014;8(6):2481-4. http://doi.org/10.3892/ol.2014.2532.
    7. Mikami Y, et al. Endocervical glandular lesions exhibiting gastric differentiation: an emerging spectrum of benign, premalignant, and malignant lesions. Adv Anat Pathol 2013;20(4):227-37. http://doi.org/10.1097/PAP.0b013e31829c2d66.
    8. Park KJ, et al. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus. Am J Surg Pathol 2011;35(5):633-46. http://doi.org/10.1097/PAS.0b013e31821534b9.
    9. Kaminski PF, et al. Minimal deviation carcinoma (adenoma malignum) of the cervix. Int J Gynecol Pathol 1983;2(2):141-52.
    10. Ishii K, et al. Cytologic and cytochemical features of adenoma malignum of the uterine cervix. Cancer Cytopathol 1999;87(5):245-53. https://doi.org/10.1002/(SICI)1097-0142(19991025)87:5<245::AID-CNCR2>3.0.CO;2-0
    11. Gilks CB, et al. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989;13(9):717-29.
    12. Kawauchi S, et al. Is lobular endocervical glandular hyperplasia a cancerous precursor of minimal deviation adenocarcinoma?: a comparative molecular-genetic and immunohistochemical study. Am J Surg Pathol 2008;32(12):1807-15. http://doi.org/10.1097/PAS.0b013e3181883722.
    13. Li G, et al. Minimal deviation adenocarcinoma of the uterine cervix. Int J Gynaecol Obstet 2010;110(2):89-92. http://doi.org/10.1016/j.ijgo.2010.03.016.
    14. Ito M, et al. Peutz-Jeghers syndrome-associated atypical mucinous proliferation of the uterine cervix: a case of minimal deviation adenocarcinoma ('adenoma malignum’) in situ. Pathol Res Pract 2012;208(10):623-7. http://doi.org/10.1016/j.prp.2012.06.008
    15. Guo F, et al. Diagnostic challenges in minimal deviation adenocarcinoma of the uterine cervix: A report of two cases and review of the literature. Mol Clin Oncol 2013;1(5):833-8. http://doi.org/10.3892/mco.2013.144
    16. Itoh K, et al. A comparative analysis of cross sectional imaging techniques in minimal deviation adenocarcinoma of the uterine cervix. BJOG 2000;107(9):1158-63.
    17. Mills KE, et al. Adenoma malignum presenting with profound hyponatremia. J Obstet Gynaecol Can 2015;37(7):624-7. DOI: https://doi.org/10.1016/S1701-2163(15)30200-0
    18. Mowat A, Land R. Adenoma malignum presenting as urinary incontinence. Int Urogynecology J 2014;25(9):1287-9. http://doi.org/10.1007/s00192-014-2348-3.
    19. Ki EY, et al. Adenoma malignum of the uterine cervix: report of four cases. World J Surg Oncol 2013;11:168. http://doi.org/10.1186/1477-7819-11-168
    20. Utsugi K, et al. Utility of the monoclonal antibody HIK1083 in the diagnosis of adenoma malignum of the uterine cervix. Gynecol Oncol 1999;75(3):345-8. http://doi.org/10.106/gyno.1999.5622
    21. Gusserow A. Ueber sarcome des uterus. Arch Gynakol 1870;1:240-51.
    22. Silverberg SG, et al. Minimal deviation adenocarcinoma («adenoma malignum») of the cervix: a reappraisal. Am J Obstet Gynecol 1975;121(7):971-5.
    23. Kurman RJ, et al. WHO Classification of Tumours of Female Reproductive Organs. 4th ed. Lyon: International Agency for Research on Cancer (IARC); 2014. Disponible en: http://apps.who.int/bookorders/anglais/detart1.jsp?codlan=1&codcol=70&codcch=4006
    24. Park SB, et al. Adenoma malignum of the uterine cervix: ultrasonographic findings in 11 patients. Ultrasound Obstet Gynecol 2011;38(6):716-21. http://doi.org/10.1002/uog.9078.

Comentarios